Betnovate Scalp Application Use In Pregnancy & Lactation

Fertility: There are no data in humans to evaluate the effect of topical corticosteroids on fertility.
Pregnancy: There are limited data from the use of Betamethasone (as valerate) (Betnovate) Solution for Scalp Application in pregnant women. Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development (see Pharmacology: Toxicology: Non-Clinical Information under Actions).
The relevance of this finding to humans has not been established; however, administration of Betamethasone (as valerate) (Betnovate) Solution for Scalp Application during pregnancy should only be considered if the expected benefit to the mother outweighs the risk to the foetus. The minimum quantity should be used for the minimum duration.
Lactation: The safe use of topical corticosteroids during lactation has not been established.
It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable amounts in breast milk. Administration of Betamethasone (as valerate) (Betnovate) Solution for Scalp Application during lactation should only be considered if the expected benefit to the mother outweighs the risk to the infant.
If used during lactation Betamethasone (as valerate) (Betnovate) Solution for Scalp Application should not be applied to the breasts to avoid accidental ingestion by the infant.